TITLE

Canadians Prefer Pill Over Inhaled Flu Medication

PUB. DATE
December 1999
SOURCE
Worldwide Biotech;Dec99, Vol. 11 Issue 12, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Provides information on the study `Usage and Attitude Study Among Canadians,' surveying the form of influenza medication preferred of Canadian patients and physicians. Methodology; Results; Implications.
ACCESSION #
2573162

 

Related Articles

  • We may be over the flu. N.H.; Hooper, Narelle // BRW;2/19/96, Vol. 18 Issue 6, p90 

    Reports on an anti-influenza drug. Molecular structure of the viral protein; Clinical trials.

  • Daily Capsule Bolsters Flu-Fighting Arsenal.  // FDA Consumer;Jan/Feb2000, Vol. 34 Issue 1, p4 

    Details the effectiveness of Tamiflu (oseltamivir phosphate) in shortening the symptoms of influenza. Type of influenza where Tamiflu is recommended; When to start treatment with Tamiflu; Dosage; Result of clinical trials; Side effects.

  • New drugs should help fight influenza this winter. Schnirring, Lisa // Physician & Sportsmedicine;Nov99, Vol. 27 Issue 12, p15 

    Focuses on a class of medication for treating influenza. Ability of neuraminidase inhibitors to shorten the duration of the illness; Increase in viral inactivation by respiratory mucus; Therapeutic indications; Management of influenza in sports.

  • New flu drug `to cost NHS ...115m'.  // Public Finance;09/10/99, p13 

    Reports on the cost of a flu drug that was launched in Great Britain in September 1999. Effect of the price on Britain's National Health Service; Patient's increased expectations on the drug.

  • New neuraminidase inhibitors for influenza: Current and potential therapeutic roles. Gonzalez, III, Luis S. // Formulary;Oct2000, Vol. 35 Issue 10, p812 

    Reports on the development of antiviral agents, zanamivir and oseltamivir, for the treatment of influenza. Existing antiviral agents for influenza; Specific activity of the agents against influenza virus neuraminidase; Role of neuraminidase in influenza virus replication; Influenza virus A and...

  • Influenza: naught for our comfort.  // British Medical Journal;5/5/1979, Vol. 1 Issue 6172, p1164 

    Examines the nature of the influenza virus in Great Britain. Lack of influenza vaccines and effective chemotherapy to prevent the virus; Causes of the virus; Inhibitory effects of amantadine.

  • Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance. Hensley, Scott E.; Das, Suman R.; Gibbs, James S.; Bailey, Adam L.; Schmidt, Loren M.; Bennink, Jack R.; Yewdell, Jonathan W. // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Drugs inhibiting the influenza A virus (IAV) neuraminidase (NA) are the cornerstone of anti-IAV chemotherapy and prophylaxis in man. Drug-resistant mutations in NA arise frequently in human isolates, limiting the therapeutic application of NA inhibitors. Here, we show that antibody-driven...

  • Anti-flu drug may not reduce death rate. Yamey, Gavin // BMJ: British Medical Journal (International Edition);09/11/99, Vol. 319 Issue 7211, p659 

    Reports on the admission of GlaxoWellcome that its drug to treat influenza zanamivir (Relenza) may not reduce mortality from flu. Need for further clinical studies in this field; Move of GlaxoWellcome in sending flu management pack to all primary care groups in England; How to reduce death rates...

  • The Healing Power of Plants. Walker, Timothy // Washington Park Arboretum Bulletin;Winter2007, Vol. 68 Issue 4, p20 

    The article presents stories about the role of plants in medicine. In October 2005, at the height of the bird flu scare, a London newspaper reported that a plant, known as star anise or Illicium verum, could provide the only treatment for the flu's symptom. In the 1960s, Jonathan Hartwell of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics